Ethics of deep brain stimulation for neuropsychiatric disorders

• Published in: Neurosurgical review 2024-08, Vol.47 (1), p.479, Article 479
• Main Authors: Aydin, Serhat, Darko, Kwadwo, Detchou, Donald, Barrie, Umaru
• Format: Article
• Language: English
• Subjects: Correspondence; Deep Brain Stimulation - ethics; Deep Brain Stimulation - methods; Humans; Informed Consent; Medicine; Medicine & Public Health; Mental Disorders - therapy; Neurosurgery; Obsessive-Compulsive Disorder - therapy; Quality of Life
• ISSN: 1437-2320; 1437-2320
• DOI: 10.1007/s10143-024-02746-w

Deep Brain Stimulation (DBS) has emerged as a revolutionary neurosurgical technique with significant implications for the treatment of various neuropsychiatric disorders. Initially developed for movement disorders like Parkinson’s disease, DBS has expanded to psychiatric conditions such as obsessive-compulsive disorder, depression, anorexia nervosa, dystonia, essential tremor, and Tourette’s syndrome. This paper explores the clinical efficacy and ethical considerations of DBS in treating these disorders. While DBS has shown substantial promise in alleviating symptoms and improving quality of life, it raises ethical challenges, including issues of informed consent, patient selection, long-term management, and equitable access to treatment. The irreversible nature of DBS, potential adverse effects, and the high cost of the procedure necessitate a rigorous ethical framework to guide its application. The ongoing evolution of neuromodulation requires continuous ethical analysis and the development of guidelines to ensure that DBS is used responsibly and equitably across different patient populations. This paper underscores the need for a balanced approach that integrates clinical efficacy with ethical considerations to optimize patient outcomes and ensure sustainable practice.